In the literature, clinical observations by Qi and coworkers suggest that prolonged survival of patients with IDH mutated gliomas is primarily linked to a less aggressive biological behavior assessed on the basis of preferred areas for tumorigenesis and magnetic resonance imaging (MRI) characteristics [113]. This evidence concerns the gene IDH1 and central nervous system cancer.